| Net loss | -4M |
| Allowance for doubtful accounts | |
| Depreciation and amortization | 784K |
| Inventory valuation charges | |
| Stock-based compensation | 519K |
| Other non-cash items | |
| Accounts receivable | -4.8M |
| Advance billings | |
| Inventories | 929K |
| Prepaid expenses and other current assets | 802K |
| Other assets | |
| Accounts payable | -2.91M |
| Accrued liabilities | -3.3M |
| Deferred revenue | 381K |
| Income taxes payable, non-current and other liabilities | |
| Net cash provided by (used in) operating activities | -11.93M |
| Purchases of available-for-sale investments | |
| Maturities of available-for-sale investments | |
| (Increase) decrease in restricted cash | |
| Purchases of property and equipment | -454K |
| Net cash from investing activities | -451K |
| Proceeds from issuance of common stock, net | -79K |
| Cash flows from financing activities | -79K |
| Effect of exchange rate changes on cash and cash equivalents | 36K |
| Net increase (decrease) in cash and cash equivalents | -12.42M |
| Cash and cash equivalents, beginning of period | 33.43M |
| Cash and cash equivalents, end of period | 21.01M |